Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Current Leases (2019 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Current Leases for 7 consecutive years, with $21.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Leases rose 1843.07% to $21.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $21.2 million, a 1843.07% increase, with the full-year FY2025 number at $21.2 million, up 1843.07% from a year prior.
  • Current Leases was $21.2 million for Q4 2025 at Acadia Healthcare Company, down from $21.5 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $31.9 million in Q2 2021 to a low of $990000.0 in Q3 2021.
  • A 5-year average of $13.5 million and a median of $18.7 million in 2021 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: crashed 96.92% in 2021, then skyrocketed 2573.03% in 2022.
  • Acadia Healthcare Company's Current Leases stood at $990000.0 in 2021, then surged by 2573.03% to $26.5 million in 2022, then dropped by 0.74% to $26.3 million in 2023, then plummeted by 95.85% to $1.1 million in 2024, then surged by 1843.07% to $21.2 million in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Current Leases are $21.2 million (Q4 2025), $21.5 million (Q3 2025), and $22.6 million (Q2 2025).